Radiolabeled antibody in the treatment of primary and metastatic liver malignancies.
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage*; D001661:Biliary Tract Neoplasms / Q000532:radiotherapy; D002272:Carcinoembryonic Antigen; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000532:radiotherapy*; D003110:Colonic Neoplasms / Q000532:radiotherapy; D004317:Doxorubicin / Q000627:therapeutic use; D005293:Ferritins / Q000276:immunology; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D005779:Immunodiffusion; D008113:Liver Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000556:secondary; D008114:Liver Neoplasms, Experimental / Q000532:radiotherapy; D051381:Rats; D012004:Rectal Neoplasms / Q000532:radiotherapy
D000906:Antibodies; D002272:Carcinoembryonic Antigen; D004317:Doxorubicin; D005293:Ferritins; D005472:Fluorouracil